$4.87
0.5913.79%
In chiusura: -
$4.88
0.010000.21%
After hour: Oct 3, 7:43 PM EDT
Larimar Therapeutics segnala gli utili su base trimestrale. Questi report sugli utili trimestrali offrono agli investitori uno sguardo ai risultati finanziari di un'azienda per un periodo di 3 mesi. I report sugli utili includono quasi sempre i risultati EPS e i ricavi.
Analizza lo storico degli utili di Larimar Therapeutics utilizzando ordinamenti e filtri avanzati.
Get Alert | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
LRMR | Larimar Therapeutics | -$0.24 | -$0.41 | — | — | $0.00 | — | — | — | 10/29/2025 | |
LRMR | Larimar Therapeutics | -$0.34 | -$0.48 | -$0.41 | 14.58% | $0.00 | — | $0.00 | — | 08/14/2025 | |
LRMR | Larimar Therapeutics | -$0.27 | -$0.41 | -$0.46 | -12.20% | $0.00 | — | $0.00 | — | 04/30/2025 | |
LRMR | Larimar Therapeutics | -$0.30 | -$0.32 | -$0.45 | -40.62% | $0.00 | — | $0.00 | — | 03/24/2025 | |
LRMR | Larimar Therapeutics | -$0.21 | -$0.37 | -$0.24 | 35.14% | $0.00 | — | $0.00 | — | 10/30/2024 | |
LRMR | Larimar Therapeutics | -$0.19 | -$0.30 | -$0.34 | -13.33% | $0.00 | — | $0.00 | — | 08/07/2024 | |
LRMR | Larimar Therapeutics | -$0.15 | -$0.24 | -$0.27 | -12.50% | $0.00 | — | $0.00 | — | 05/09/2024 | |
LRMR | Larimar Therapeutics | -$0.21 | -$0.25 | -$0.30 | -20.00% | $0.00 | — | $0.00 | — | 03/14/2024 | |
LRMR | Larimar Therapeutics | -$0.37 | -$0.22 | -$0.21 | 4.55% | $0.00 | — | $0.00 | — | 11/14/2023 | |
LRMR | Larimar Therapeutics | -$0.47 | -$0.19 | -$0.19 | 0.00% | $0.00 | — | $0.00 | — | 08/10/2023 | |
LRMR | Larimar Therapeutics | -$0.49 | -$0.25 | -$0.15 | 40.00% | $0.00 | — | $0.00 | — | 05/15/2023 | |
LRMR | Larimar Therapeutics | -$0.50 | -$0.37 | -$0.21 | 43.24% | $0.00 | — | $0.00 | — | 03/14/2023 | |
LRMR | Larimar Therapeutics | -$0.92 | -$0.42 | -$0.37 | 11.90% | $0.00 | — | $0.00 | — | 11/10/2022 | |
LRMR | Larimar Therapeutics | -$0.79 | — | -$0.47 | — | $0.00 | — | $0.00 | — | 08/11/2022 | |
LRMR | Larimar Therapeutics | -$0.76 | — | -$0.49 | — | $0.00 | — | $0.00 | — | 05/12/2022 | |
LRMR | Larimar Therapeutics | -$0.89 | — | -$0.50 | — | $0.00 | — | $0.00 | — | 03/25/2022 | |
LRMR | Larimar Therapeutics | -$0.64 | -$0.64 | -$0.92 | -43.75% | $0.00 | — | $0.00 | — | 11/12/2021 | |
LRMR | Larimar Therapeutics | -$1.21 | -$0.77 | -$0.79 | -2.60% | $0.00 | — | $0.00 | — | 08/12/2021 | |
LRMR | Larimar Therapeutics | -$1.10 | -$0.72 | -$0.76 | -5.56% | — | — | $0.00 | — | 05/10/2021 | |
LRMR | Larimar Therapeutics | -$1.00 | — | -$0.89 | — | — | — | $0.00 | — | 03/04/2021 | |
LRMR | Larimar Therapeutics | -$1.42 | — | -$0.64 | — | — | — | $0.00 | — | 11/10/2020 |
Trimestre fiscale | Data segnalata | EPS effettivo | EPS stimato | Sorpresa% |
---|---|---|---|---|
Q2 | 2025-08-14 | $-0.41 | $-0.48 | 14.6 % |
Q1 | 2025-04-30 | $-0.46 | $-0.41 | -12.2 % |
Q4 | 2025-03-24 | $-0.45 | $-0.32 | -40.6 % |
Q3 | 2024-10-30 | $-0.24 | $-0.37 | 35.1 % |
Trimestre fiscale | Data segnalata | Entrate effettive | Entrate stimate | Sorpresa% |
---|---|---|---|---|
Si prevede che Larimar Therapeutics (LRMR) fornisca risultati il ottobre 29, 2025. Gli ultimi risultati sono stati pubblicati il agosto 14, 2025 per il Q2.
L'EPS effettivo era $-0.41, che superato la stima di $-0.48.
Le entrate effettive sono state $0K, che centrato la stima di $0K.
Sfoglia stime sugli utili, EPS e ricavi su tutte le azioni.